2025Year11Month20Day，Global medical technology giant Medtronic (Medtronic) announced the completion of key management adjustments,Jim·Pecher (Jim Peichel) has officially been promoted to Chief Technology Officer (CTO), succeeding the retiring Ken Washington (Ken Washington）。This personnel change occurred two days after the company's Q2 financial report was released, highlighting the effectiveness of the technology innovation-driven strategy with strong growth in the cardiovascular business.

According to PecherLinkedInDynamic Display,Its own1999Joined Medtronic as a software engineering intern,25He gradually advanced from a grassroots technical position to the core management level over the years. Prior to this promotion, he served as the Vice President of the Cardiac Implant Technology Development Center, leading the development of several groundbreaking products.

In the social media statement announcing the promotion, Pecher emphasized:"Medtronic's technical talent community is at the core of its mission, serving asCTO"I will be committed to becoming the spokesperson for this innovative group." His career has been deeply tied to the technological iteration trajectory of Medtronic, from early software engineering to the development of cardiac implant devices, and now to the formulation of overarching technology strategies.

This personnel change reflects the deep logic of multinational medical device companies in technical talent management. Pechel's promotion path embodies"Internal Training"+The typical characteristic of "long-term沉淀," while Washington's cross-industry experience reflects Medtronic's openness to external innovation resources. In the medical technology industry, integration is accelerating.AIAgainst the backdrop of cutting-edge technologies such as robotics, Medtronic balances technology inheritance with breakthrough innovation through a dual-track talent strategy, ensuring the continuity of core technologies while introducing cross-disciplinary thinking through the recruitment of external executives.

PredecessorCTOKen Washington's departure arrangement is of landmark significance in the industry. Washington formerly served as Vice President of Consumer Robotics at Amazon and Ford Motor Company.CTO, whose cross-industry experience once infused Medtronic with Silicon Valley-style innovation logic. After retirement, Washington will take up a position at a medical device supplier.TE ConnectivityBoard members, and serve asAIMedical CompanyiGENTIC AIChairman of the Board, continuing its resource integration capabilities in the intersection of medical technology and cutting-edge technology. This handover coincides with a critical node in Medtronic's technological innovation cycle – the cardiovascular business achieved in the second quarter.10.8%Year-on-year growth, leading Wall Street expectations, among whichAfferaPulse Field Ablation Technology, LeadlessMicraCore products such as pacemakers continue to contribute to growth momentum.

Medtronic's current technology strategy focuses on the commercialization of breakthrough therapies in the cardiovascular field.AfferaPulse Field Ablation Technology, as a new generation solution for atrial fibrillation treatment, has demonstrated significant efficacy through clinical validation.MicraLeadless pacemakers revolutionize the form of traditional cardiac implantable devices through miniaturized design, enhancing patient comfort and surgical safety. The Q2 financial report shows that the cardiovascular business10.8%The growth rate far exceeds the industry average, demonstrating the direct role of technological innovation in driving market share.Pecher reiterated in his inaugural statement:"Innovation is the lifeblood of Medtronic. We will continue to push the boundaries of technology to provide more impactful solutions for patients worldwide."

Pecher wrote at the end of the letter to employees:"Thank you to all supporters, let us jointly embark on the next chapter—continuing our mission to alleviate pain, restore health, and extend life." With the newCTOOfficially assuming duties, Medtronic's technology strategy will enter a new era.Instrument之家 will also continue to pay attention.。